Do you have to be on Wegovy for life — and what happens if you stop?

Why weight tends to return when Wegovy stops

The reason most people regain weight after stopping is biological, not a failure of effort. Semaglutide works by activating GLP-1 receptors that slow gastric emptying and reduce appetite signals from the gut. While you're taking it, those signals are consistently dampened. Stop the medicine, and the biology reasserts itself: hunger hormone levels climb back, the stomach empties faster, and food feels less filling than it did during treatment.

A question our prescribers hear most weeks is some version of "can I just do a course and come off?", and the honest answer is that some people do manage sustained results after stopping, particularly those who have built strong dietary habits during treatment. But the published evidence is sobering. A large trial following participants who stopped semaglutide 2.4mg found that, by one year post-treatment, average weight loss had reduced from roughly 15% to around 5% of body weight. The appetite changes that treatment corrected simply returned. You can read more about how semaglutide works if the mechanism matters to you.

This is not unique to Wegovy. It reflects how obesity works as a condition: it is chronic, driven by physiology, and tends to recur when treatment stops. That framing is important. It takes the moral weight off the question and puts the clinical focus where it belongs.

What 'long-term' actually means in clinical guidance

NICE's recommendation for semaglutide (published under technology appraisal TA875) specifies use within specialist weight management services for a maximum of two years. That two-year limit is the NHS pathway, built around a model where specialist support is provided alongside the medicine. If less than 5% weight loss has occurred after six months at the maintenance dose, continuing is reviewed.

Private prescribing sits outside that framework. Duration is a clinical decision between you and your prescriber, reassessed at every repeat order. There is no automatic cut-off, but there is also no automatic continuation: each review considers whether treatment is still working, still appropriate, and still in your interest.

For context on whether staying on Wegovy long-term is the right approach for you, the answer almost always involves your prescriber running through your current health markers, any side effects you've experienced, and your own preferences. That conversation matters more than a blanket policy.

Stopping Wegovy: what to think about before you decide

If you are thinking about coming off Wegovy, the key questions are: why, and what is the plan afterwards? Stopping because side effects are unmanageable or because a medical reason has emerged is a clear clinical rationale. Stopping because you feel you have reached your goal is understandable, but the evidence suggests a structured plan (usually involving lifestyle changes to compensate for the returning appetite) significantly affects whether weight is maintained.

There is no requirement to taper Wegovy in the way some medicines must be reduced gradually, but your prescriber will advise on the right approach for your dose and situation. The NHS England page on weight management injections covers the wraparound diet and activity support that is supposed to accompany treatment, and the logic holds whether you are on the NHS or privately: what you build during treatment shapes what happens when it ends.

Some people do choose to stay on Wegovy indefinitely, treating it as they would any long-term medicine for a chronic condition, and if you are wondering whether Wegovy is intended to be a lifelong treatment, the clinical picture is more nuanced than a simple yes or no. Others take a planned break and restart if needed. Both are legitimate approaches when made with clinical input. The question of whether taking Wegovy for life is a safe and suitable option is one of safety and suitability, not just preference, and if you want a fuller picture of what staying on Wegovy for life actually involves, including the evidence and clinical considerations, that is worth reading before making any decision about duration.

What this means in practice at a regulated pharmacy

At nume, every repeat order is clinically reviewed before it is dispensed. There are no rolling subscriptions, no automatic refills. A GPhC-registered prescriber looks at your progress and health before authorising each supply. That structure naturally creates the kind of regular review point that long-term treatment with any prescription medicine should include.

If you have questions about duration, stopping, or switching medicine, the aftercare team is available seven days a week. That is not just a service feature; for a decision as consequential as stopping or continuing a treatment, having a real clinician to speak to matters. You can explore what that process looks like on our about us page, or if you are still weighing up whether Wegovy is suitable for you at all, our weight-loss treatment overview covers the options side by side.

Ready to have this conversation with a prescriber? Start your free consultation and get a same-day clinical review.